DermTech Inc Sustainability Reports
DermTech, Inc. develops and commercializes non-invasive genomic patch tests for the early detection and diagnosis of skin cancer, primarily melanoma. The company operates a clinical laboratory to extract and analyze patient RNA and DNA collected via adhesive smart stickers.
Sector: Healthcare & social services
Country: United States
Exchange: OTC Markets
FIGI: BBG00H19F193
1 reports from 2022 to 2022
Company Profile
DermTech, Inc. develops and commercializes non-invasive genomic patch tests for the early detection and diagnosis of skin cancer, primarily melanoma. The company operates a clinical laboratory to extract and analyze patient RNA and DNA collected via adhesive smart stickers.
Reports
1 total
Limited sustainability disclosure available
This company only publishes Annual Reports without dedicated sustainability sections.
Years
